Sort by
Items per page

Send to

Choose Destination

Best matches for fracture AND malignant neoplasm of breast AND survivors:

Search results

Items: 1 to 20 of 72


Impact of an osteoporosis specialized unit on bone health in breast cancer survivals treated with aromatase inhibitors.

Martínez P, Galve E, Arrazubi V, Sala MÁ, Fernández S, Pérez CE, Arango JF, Torre I.

Reumatol Clin. 2017 Oct 11. pii: S1699-258X(17)30229-2. doi: 10.1016/j.reuma.2017.08.005. [Epub ahead of print] English, Spanish.


Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?

Ramchand SK, Lim E, Grossmann M.

Clin Endocrinol (Oxf). 2016 Nov;85(5):689-693. doi: 10.1111/cen.13172. Epub 2016 Sep 1. Review.


Effect of a randomized controlled exercise trial on bone outcomes: influence of adjuvant endocrine therapy.

Knobf MT, Jeon S, Smith B, Harris L, Kerstetter J, Thompson AS, Insogna K.

Breast Cancer Res Treat. 2016 Feb;155(3):491-500. doi: 10.1007/s10549-016-3693-3. Epub 2016 Feb 5.


Training-related improvements in musculoskeletal health and balance: a 13-week pilot study of female cancer survivors.

Almstedt HC, Grote S, Perez SE, Shoepe TC, Strand SL, Tarleton HP.

Eur J Cancer Care (Engl). 2017 Mar;26(2). doi: 10.1111/ecc.12442. Epub 2016 Jan 18.


Fracture risk and adjuvant therapies in young breast cancer patients: a population-based study.

Chang CH, Chen SJ, Liu CY.

PLoS One. 2015 Jun 24;10(6):e0130725. doi: 10.1371/journal.pone.0130725. eCollection 2015.


Weight Lifting and Physical Function Among Survivors of Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial.

Brown JC, Schmitz KH.

J Clin Oncol. 2015 Jul 1;33(19):2184-9. doi: 10.1200/JCO.2014.57.7395. Epub 2015 May 11.


Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case-control study.

Sheean P, Liang H, Schiffer L, Arroyo C, Troy K, Stolley M.

J Cancer Surviv. 2016 Feb;10(1):21-30. doi: 10.1007/s11764-015-0448-9. Epub 2015 Mar 29.


Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial.

Greenspan SL, Vujevich KT, Brufsky A, Lembersky BC, van Londen GJ, Jankowitz RC, Puhalla SL, Rastogi P, Perera S.

Osteoporos Int. 2015 Jun;26(6):1857-64. doi: 10.1007/s00198-015-3100-7. Epub 2015 Mar 20.


[Prevalence of low bone mineral density in postmenopausal breast cancer survivors].

Poloni PF, Omodei MS, Nahas-Neto J, Uemura G, Véspoli Hde L, Nahas EA.

Rev Bras Ginecol Obstet. 2015 Jan;37(1):30-5. doi: 10.1590/SO100-720320140005134. Portuguese.


Minimal-trauma fracture in women with breast cancer surviving for at least 5 years from diagnosis.

Robinson PJ, Bell RJ, Zecena Morales CS, Fradkin P, Davis SR.

Osteoporos Int. 2015 Feb;26(2):795-800. doi: 10.1007/s00198-014-2945-5. Epub 2014 Oct 31.


Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer. A cohort study based on 8,507 patients.

Dybvik E, Furnes O, Fosså SD, Trovik C, Lie SA.

Acta Orthop. 2014 Dec;85(6):652-6. doi: 10.3109/17453674.2014.963784. Epub 2014 Sep 19.


Bone health in cancer patients: ESMO Clinical Practice Guidelines.

Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii124-37. doi: 10.1093/annonc/mdu103. Epub 2014 Apr 29.


Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner.

Kenyon M, Mayer DK, Owens AK.

J Obstet Gynecol Neonatal Nurs. 2014 May-Jun;43(3):382-98. doi: 10.1111/1552-6909.12300. Epub 2014 Apr 1. Review.


High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study.

Hutchins-Wiese HL, Picho K, Watkins BA, Li Y, Tannenbaum S, Claffey K, Kenny AM.

Nutr Cancer. 2014;66(1):68-76. doi: 10.1080/01635581.2014.847964. Epub 2013 Nov 25.


Disentangling the body weight-bone mineral density association among breast cancer survivors: an examination of the independent roles of lean mass and fat mass.

George SM, McTiernan A, Villaseñor A, Alfano CM, Irwin ML, Neuhouser ML, Baumgartner RN, Baumgartner KB, Bernstein L, Smith AW, Ballard-Barbash R.

BMC Cancer. 2013 Oct 25;13:497. doi: 10.1186/1471-2407-13-497.


Skeletal manifestations of treatment of breast cancer on premenopausal women.

Doo L, Shapiro CL.

Curr Osteoporos Rep. 2013 Dec;11(4):311-8. doi: 10.1007/s11914-013-0181-0. Review.


Fracture in asian women with breast cancer occurs at younger age.

Tsai CH, Muo CH, Tzeng HE, Tang CH, Hsu HC, Sung FC.

PLoS One. 2013 Sep 12;8(9):e75109. doi: 10.1371/journal.pone.0075109. eCollection 2013. Erratum in: PLoS One. 2013;8(9). 10.1371/annotation/da898acf-fd59-480d-bea1-c91d13f43a5c. Tsa, Chun-Hao [corrected to Tsai, Chun-Hao].


Bone health issues in breast cancer survivors: a Medicare Current Beneficiary Survey (MCBS) study.

Peppone LJ, Mustian KM, Rosier RN, Carroll JK, Purnell JQ, Janelsins MC, Morrow GR, Mohile SG.

Support Care Cancer. 2014 Jan;22(1):245-51. doi: 10.1007/s00520-013-1967-4. Epub 2013 Sep 17.


Fracture risk in older, long-term survivors of early-stage breast cancer.

Pawloski PA, Geiger AM, Haque R, Kamineni A, Fouayzi H, Ogarek J, Petersen HV, Bosco JL, Thwin SS, Silliman RA, Field TS.

J Am Geriatr Soc. 2013 Jun;61(6):888-95. doi: 10.1111/jgs.12269. Epub 2013 May 6.

Supplemental Content

Loading ...
Support Center